Recently, the management of patients with low-risk differentiated non-medullary thyroid
cancer (DTC), including papillary and follicular thyroid carcinoma subtypes, has been …

Implementing high-quality randomized controlled trials is difficult for patients with 1–4 cm
low-risk differentiated thyroid carcinoma (DTC). Controversy exists regarding whether …

Background and Objectives We aimed to evaluate the disease specific‐survival (DSS) of
patients with Medullary Thyroid Cancer (MTC) confined to the central neck based on the …

Background: The extent of thyroidectomy for low-risk well-differentiated thyroid cancer
(WDTC) remains controversial. Historically, total thyroidectomy (TT) has been recommended …

Background: Surgical extent in the management of well-differentiated thyroid cancer (DTC)
remains a recurrent subject of debate. This is especially relevant in low-risk DTC of 1–4 cm …

Background: The approach for surgical treatment of patients with low-/intermediate-risk
T1T2N0/Nx well-differentiated thyroid cancer (WDTC)—total thyroidectomy (TT) versus …

Background Controversies remain about the ideal risk-based surgical approach for
differentiated thyroid cancer (DTC). Methods At a single tertiary care institution, 370 …

Objective For 1–4 cm differentiated thyroid cancer (DTC), current ATA guideline
recommended hemithyroidectomy (HT) as an acceptable alternative initial procedure to total …

The surgical treatment of the intermediate-risk DTC (1–4 cm) remains still controversial. We
analyzed the current practice in Italy regarding the surgical management of intermediate-risk …

Background: Cytological limitations pose a challenge to preoperative diagnosis of medullary
thyroid carcinoma (MTC) and therefore, a significant subset of patients is only diagnosed …